DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (NYSE Amex: NEOP) announced today that it has reached an agreement with Platinum Montaur Life Sciences, LLC and its affiliate Platinum Partners Value Arbitrage Fund L.P. (together, “Platinum”) regarding the nomination of Neoprobe Corporation directors and other matters related to Neoprobe’s 2011 Annual Meeting.
